Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study

SIMPLE SUMMARY: Graft-versus-host disease (GVHD) remains a main cause of morbidity and mortality in patients receiving allogeneic hematopoietic stem cell transplantation. Among GVHD prophylaxis regimens, antilymphocyte serum (ATG/ATLG) has been widely used in both unrelated donor transplant and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Schirico, Mariella, Passera, Roberto, Gill, Jessica, Dellacasa, Chiara, Dogliotti, Irene, Giaccone, Luisa, Zompi, Sofia, Busca, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216361/
https://www.ncbi.nlm.nih.gov/pubmed/37345098
http://dx.doi.org/10.3390/cancers15102761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216361/
https://www.ncbi.nlm.nih.gov/pubmed/37345098
http://dx.doi.org/10.3390/cancers15102761

Ejemplares similares